Skip to main content

Day: December 19, 2024

Entrée Resources Wins Arbitration Decision

VANCOUVER, British Columbia, Dec. 19, 2024 (GLOBE NEWSWIRE) — Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) is pleased to announce that today a partial final award (the “Award”) was made by the three-member international arbitration Tribunal appointed in connection with the Company’s binding arbitration proceedings against its joint venture partner Oyu Tolgoi LLC (“OTLLC”) and Turquoise Hill Resources Ltd. (together, the “Respondents”). The Tribunal has ruled in favor of Entrée on all issues and dismissed the Respondents’ counterclaims. Stephen Scott, the Company’s President & CEO commented, “This Award represents a tremendous outcome for the Company and provides much needed certainty for all Oyu Tolgoi project stakeholders as we endeavor to keep Lift 1 Panel 1 development work on schedule.” The...

Continue reading

Xali Gold Announces Stock Options Grant and Annual General Meeting Voting results

VANCOUVER, British Columbia, Dec. 19, 2024 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the ”Company”) reports that, pursuant to the terms and conditions of its Omnibus Equity Incentive Plan, an aggregate of 4,100,000 stock options to purchase common shares of the Company have been granted to certain directors, officers and consultants of the Company. The options are exercisable for a period of five years at a price of $0.05 per share. Xali Gold is pleased to announce the results of the Company’s Annual General Meeting of Shareholders (the “Meeting”) held on December 19th, 2024. A total of 14,006,597 common shares of the Company were voted at the meeting, representing 9.83% of the total number of issued and outstanding shares of the Company. At the Meeting, all five director nominees listed in the Company’s...

Continue reading

Preferred Bank Announces Additional Q4 Expense

LOS ANGELES, Dec. 19, 2024 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), (“the Bank”), an independent commercial bank, today announced that the Bank had uncovered an unreconciled difference in its calculation of its right of use asset (“ROU”) and lease liabilities. As a result of this error, the Bank will record $8.1 million on a pre-tax basis of occupancy expense in the fourth quarter of 2024. On an after-tax basis, this will reduce fourth quarter diluted earnings per share by approximately $0.43. In January of 2019, the Bank adopted ASC 842, Accounting for Leases. This accounting statement requires entities capitalize leases that are longer than one year. The effect being that lease expense is recognized more evenly over the life of the lease, rather than recording lease expense as incurred. When the Bank adopted ASC 842,...

Continue reading

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market

New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and PermeaDerm Cohealyx expected to triple AVITA Medical’s addressable market in burnsVALENCIA, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Cohealyx™, a new collagen-based dermal matrix branded by AVITA Medical and co-developed with Regenity Biosciences. Cohealyx is designed for tissue integration and revascularization to facilitate wound healing, reduce treatment timelines, and improve patient outcomes in the treatment of full-thickness wounds. Burns and full-thickness...

Continue reading

Mattr Corp. Announces Closing of Debt Subscription Receipt Offering

TORONTO, Dec. 19, 2024 (GLOBE NEWSWIRE) — Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) confirmed today that it has successfully closed its previously announced private offering (the “Offering”) of debt subscription receipts (the “Subscription Receipts”) for aggregate gross proceeds of approximately $129.3 million. The Offering proceeds, less the underwriters’ fee and expenses, are being held in escrow pending the satisfaction or waiver of certain conditions, following which, the Subscription Receipts will convert into Notes, as described below. Mattr intends to use the net proceeds of the Offering to pay a portion of the purchase price for the Company’s previously announced indirect acquisition (the “Acquisition”) of all of the issued and outstanding shares of AmerCable Incorporated. Subject to the satisfaction of certain...

Continue reading

Jura Announces Highly Favorable Resolution of Arbitration Proceedings Regarding Badin IV North and South Blocks

CALGARY, Alberta, Dec. 19, 2024 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura” or the “Company”) is pleased to announce that it has received a highly favorable ruling in its International Chamber of Commerce (“ICC”) arbitration proceedings involving Jura’s operating subsidiaries, Spud Energy Pty Limited (“Spud”) and Frontier Holdings Limited (“FHL”) (together the “Claimants”), and Petroleum Exploration (Private) Limited (“PEL”), the operator of the Badin IV North and South blocks (together the “Badin Blocks”). As previously disclosed by Jura, in 2022, PEL attempted to invoke the forfeiture of FHL’s 27.5% working interest in the Badin Blocks for alleged non-payment of cash calls. The Claimants disputed PEL’s actions and the cash calls and initiated two arbitration proceedings against PEL. The first...

Continue reading

Stifel Reports November 2024 Operating Data

ST. LOUIS, Dec. 19, 2024 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported selected operating results for November 30, 2024 in an effort to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed. Ronald J. Kruszewski, Chairman and Chief Executive Officer, said, “In November, total client assets under management climbed to a record $514 billion, including a record $197 billion in fee-based assets. This represents a 4% increase from the prior month, driven by strong equity markets and financial advisor recruiting. Client money market and insured product balances increased 3% from October as growth in sweep deposits and Smart Rate balances were comparable. The operating environment for our Institutional...

Continue reading

Mission Produce™ Announces Fiscal 2024 Fourth Quarter Financial Results

Strong top and bottom-line results driven by ongoing strength of the Marketing & Distribution segment Operating cash flow for full year fiscal 2024 increased by $64.2 million versus fiscal 2023 OXNARD, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) — Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader in sourcing, producing, and distributing fresh Hass avocados with additional offerings in mangos and blueberries, today reported its financial results for the fiscal fourth quarter ended October 31, 2024. Fiscal Fourth Quarter 2024 Financial Overview:Total revenue increased 37% to $354.4 million compared to the same period last year Net income of $17.3 million, or $0.24 per diluted share, compared to $4.0 million, or $0.06 per diluted share, for the same period last year Adjusted net income of $19.6 million,...

Continue reading

OraSure Technologies Acquires Sherlock Biosciences

BETHLEHEM, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation diagnostics to consumers and healthcare providers. This acquisition expands OraSure’s innovation pipeline with the addition of Sherlock’s molecular diagnostics platform, which is able to provide rapid results with strong sensitivity and specificity in a disposable format that is well-suited for over-the-counter usage. Sherlock’s first molecular self-test is for Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (NG) which will expand OraSure’s portfolio of rapid diagnostics for sexually transmitted infections (STIs), subject to regulatory...

Continue reading

SEALSQ Announces Completion of a $25.0 Million Registered Direct Offering

Geneva, Switzerland, Dec. 19, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced that it has completed a registered direct offer to several institutional investors of 13,157,896 ordinary shares at a public offering price of $1.90, for gross proceeds of $25.0 million (the “Offering”), before deducting commissions and offering expenses. This brings the total gross proceeds from financings completed this week to $60.0 million, before deducting commissions and offering expenses. The Company confirms that, given the terms of the financings completed in the last week, it does not currently expect to enter into any further registered direct offering...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.